ArticleDiscover oncology2025
Periungual pigmented Bowen's disease infected with human papillomavirus 73 and healed with secondary intention healing.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Periungual pigmented Bowen's disease is uncommon and often overlooked in daily practice. This retrospective observational case series included periungual Bowen's disease diagnosed as by histopathology between January, 2023, and September, 2024, at Peking University People's Hospital. Clinical characteristics, HPV expression and treatment options were evaluated. Four patients (3 males and 1 female) aged 24 to 62 years old were included in the study. All lesions were pigmented and located on the right hand, with the right 3rd finger involved in 3 cases. Two patients reported trauma before the emergence of the lesion and 1 patient had acute myelocytic leukemia. HPV 73 was detected in all patients and 1 patient also carried HPV 52. One patient was treated with imiquimod. Three patients healed well after excision and secondary intention healing. This study highlights the importance of HPV 73 in periungual pigmented Bowen's disease and secondary intention healing in the periungual area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.